Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

SuperGen acquires European marketing authorizations for Nipent

Feb. 26, 2004

New tubulin polymerization inhibitors covered by Zentaris patent

Feb. 26, 2004

AstraZeneca describes new MEK inhibitors with utility in solid tumor therapy

Feb. 26, 2004

MDM2 antagonists activate p53 tumor suppressor pathway in vivo

Feb. 26, 2004

NDA submission for six-month Eligard product

Feb. 25, 2004

Vidaza NDA accepted for filing

Feb. 25, 2004

Oral phenoxodiol evaluated in phase I trial for cervical cancer

Feb. 25, 2004

Thalomid sNDA accepted for review

Feb. 25, 2004

Novel antiproliferative agents in early development at Bayer

Feb. 25, 2004

New mitotic kinesin KSP inhibitors jointly reported by Cytokinetics and GSK

Feb. 25, 2004

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent
BioWorld Science
Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...